Literature DB >> 23771545

Adolescent depression: clinical features and therapeutic strategies.

B Nardi1, G Francesconi, M Catena-Dell'osso, C Bellantuono.   

Abstract

BACKGROUND: Major depressive disorder (MDD) is a common disorder during adolescence and it is associated with an increased risk of suicide, poor school performance, impaired social skills, social withdrawal and substance abuse. Further, as many depressive episode in adolescents do not reach the diagnostic threshold for MDD, the disorder remains undetected. AIM: This review aims to provide an update of clinical features of adolescent MDD and to focus on the most appropriate therapeutic strategies to adopt in clinical practice.
MATERIALS AND METHODS: We reviewed the international literature to identify studies focusing on clinical features and therapeutic options in adolescents affected by MDD. PubMed, Medline and Cochrane Library databases were searched for English language papers.
RESULTS: The clinical picture of depression is variable with sex and age. Somatic complaints, particularly headache and fatigue, are a common presentation in adolescent MDD. Irritability is present most frequently in female and it is related to the severity of MDD. Adolescent MDD is also characterized by a high rates of suicides. The therapeutic strategy in adolescent depression includes psychotropic medications, psychotherapy or a combination of both treatments, with selection of the most appropriate strategy depending on symptom severity. As first-line treatment the traditional cognitive behavioural therapy (CBT), as well as the cognitive Post-Rationalist (PR) approach, are so far considered the goal standard.
CONCLUSIONS: The therapeutic approach to the adolescent affected by MMD should respect the person in his/her psycho-physical entirety. The intervention may help the subject in seeking a more stable and adaptable identity. It is relevant to have a good knowledge of the peculiar clinical picture of adolescent MDD in order to make an early identification of the disorder and to define an appropriate personalized therapeutic program.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23771545

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  19 in total

Review 1.  Abnormal neural activities in adults and youths with major depressive disorder during emotional processing: a meta-analysis.

Authors:  Xuqian Li; Junjing Wang
Journal:  Brain Imaging Behav       Date:  2021-04       Impact factor: 3.978

Review 2.  Annual Research Review: Defining and treating pediatric treatment-resistant depression.

Authors:  Jennifer B Dwyer; Argyris Stringaris; David A Brent; Michael H Bloch
Journal:  J Child Psychol Psychiatry       Date:  2020-02-04       Impact factor: 8.982

3.  Depressive symptoms among adolescents and older adults in Mexico City.

Authors:  Sergio Sánchez-García; Carmen García-Peña; Catalina González-Forteza; Alberto Jiménez-Tapia; Joseph J Gallo; Fernando A Wagner
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-02-01       Impact factor: 4.328

4.  Aberrant intrinsic hippocampal and orbitofrontal connectivity in drug-naive adolescent patients with major depressive disorder.

Authors:  Zilin Zhou; Yingxue Gao; Ruohan Feng; Lihua Zhuo; Weijie Bao; Kaili Liang; Hui Qiu; Lingxiao Cao; Mengyue Tang; Hailong Li; Lianqing Zhang; Guoping Huang; Xiaoqi Huang
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-09-17       Impact factor: 5.349

5.  A qualitative study exploring adolescents' experiences with a school-based mental health program.

Authors:  Pernilla Garmy; Agneta Berg; Eva K Clausson
Journal:  BMC Public Health       Date:  2015-10-21       Impact factor: 3.295

6.  Initial Findings from a Novel School-Based Program, EMPATHY, Which May Help Reduce Depression and Suicidality in Youth.

Authors:  Peter H Silverstone; Marni Bercov; Victoria Y M Suen; Andrea Allen; Ivor Cribben; Jodi Goodrick; Stu Henry; Catherine Pryce; Pieter Langstraat; Katherine Rittenbach; Samprita Chakraborty; Rutger C Engels; Christopher McCabe
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

7.  Nocebo effect in randomized clinical trials of antidepressants in children and adolescents: systematic review and meta-analysis.

Authors:  Johanna Carolina Rojas-Mirquez; Milton Jose Max Rodriguez-Zuñiga; Francisco Javier Bonilla-Escobar; Herney Andres Garcia-Perdomo; Mike Petkov; Lino Becerra; David Borsook; Clas Linnman
Journal:  Front Behav Neurosci       Date:  2014-11-03       Impact factor: 3.558

8.  The endocannabinoid/endovanilloid system and depression.

Authors:  Irena Smaga; Beata Bystrowska; Dawid Gawliński; Edmund Przegaliński; Małgorzata Filip
Journal:  Curr Neuropharmacol       Date:  2014-09       Impact factor: 7.363

9.  Disrupted Structural and Functional Connectivity in Prefrontal-Hippocampus Circuitry in First-Episode Medication-Naïve Adolescent Depression.

Authors:  Haiyang Geng; Feng Wu; Lingtao Kong; Yanqing Tang; Qian Zhou; Miao Chang; Yifang Zhou; Xiaowei Jiang; Songbai Li; Fei Wang
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

10.  Do girls with depressive symptoms exhibit more physical aggression than boys? A cross sectional study in a national adolescent sample.

Authors:  Xavier Benarous; Christine Hassler; Bruno Falissard; Angèle Consoli; David Cohen
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2015-08-22       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.